Analyzing Titan Pharmaceuticals (NASDAQ:TTNP) stock? View TTNP's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Titan Pharmaceuticals, Inc. Common Stock (TTNP) Earnings ... TTNP Titan Pharmaceuticals, Inc. Common Stock. the consensus EPS* forecast has remained the same over the past week at 999 and increased over the past month from -0.72 to …

Titan Pharmaceuticals, Inc. (TTNP) Titan Pharmaceuticals. Titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long-term, continuous drug delivery platform, ProNeura. More About Titan Pharmaceuticals Titan Pharmaceuticals, Inc. (TTNP) Stock Analysis & News ... Get breaking news and analysis on Titan Pharmaceuticals, Inc. (TTNP) stock, price quote and chart, trading and investing tools. TTNP: Titan Pharmaceuticals Inc - Stock Price ... - CNBC Get Titan Pharmaceuticals Inc (TTNP:NASDAQ) real-time stock quotes, news and financial information from CNBC.

Get Titan Pharmaceuticals Inc (TTNP:NASDAQ) real-time stock quotes, news and financial information from CNBC.

See Titan Pharmaceuticals, Inc. (TTNP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. ETFs Holding TTNP | Titan Pharmaceuticals Inc (DE) | ETF ... TTNP Description — Titan Pharmaceuticals Inc (DE) Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. TTNP:Bursa Malays Stock Quote - Lotte Chemical Titan ... Stock analysis for Lotte Chemical Titan Holding Bhd (TTNP:Bursa Malays) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Titan Pharmaceuticals, Inc. (TTNP) Analyst Ratings ...

Apr 03, 2020 · Real-time trade and investing ideas on Titan Pharmaceuticals Inc. TTNP from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. TTNP Price Target and Analyst Ratings (Titan Pharmaceuticals)

Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 1.00 

Historical index on US Stock Market : D-"Should I invest in Pitney Bowes stock?" "Should I trade "PBI" stock today?" According to our live Forecast System, Pitney Bowes Inc stock is a bad long-term (1-year) investment*. "PBI" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. TTNP Stock Price and Chart — NASDAQ:TTNP — TradingView Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in development of therapeutics for the treatment of medical disorders. Its products include Probuphine, Ropinirole Implant, and T3 Implant. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA. Earnings Whisper Number for TTNP: Titan Pharma Aug 14, 2019 · Titan Pharma (TTNP) reports earnings on 6/29/2020. Shares are down 9.2% since reporting last quarter. The Earnings Whisper Score gives the … Blnk Stock Forecast: up to 2.100 USD! - BLNK Stock Price ...

Zacks Small Cap Research - TTNP - Titan Down But Not Out

Mar-31-20 12:43PM, Penny Stocks to Buy Using Technical Analysis for April 2020 Nov-25-19 05:15AM, TTNP: Waiting for Revenue Turn Zacks Small Cap  Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the  Pharmaceuticals, Inc. Common Stock. Data is currently not available. DATA AS OF Mar 30, 2020. $0.273 0.023 9.2%. TTNP TTNP PRICE/EARNINGS & PEG 

Stock analysis for Titan Pharmaceuticals Inc (TTNP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. TTNP stock: Titan Pharmaceuticals, Inc. - Super Stock Screener Titan Pharmaceuticals, Inc.'s stock rating is based on fundamental analysis. Don't miss TTNP stock next rating changes Pitney Bowes Stock Forecast: down to 0.000001 USD? - PBI ...